vs
Side-by-side financial comparison of Atmus Filtration Technologies Inc. (ATMU) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $446.6M, roughly 1.1× Atmus Filtration Technologies Inc.). Atmus Filtration Technologies Inc. runs the higher net margin — 10.7% vs 6.8%, a 3.9% gap on every dollar of revenue. On growth, Atmus Filtration Technologies Inc. posted the faster year-over-year revenue change (9.8% vs -1.7%). Over the past eight quarters, Atmus Filtration Technologies Inc.'s revenue compounded faster (2.3% CAGR vs -0.1%).
Atmus Filtration Technologies Inc. designs, manufactures and distributes high-performance filtration products and tailored solutions. Its portfolio covers air, fuel, oil and hydraulic filtration systems, serving global automotive, heavy-duty vehicle, industrial equipment and aerospace end markets, for both original equipment manufacturers and aftermarket replacement customers.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
ATMU vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $446.6M | $493.8M |
| Net Profit | $48.0M | $33.7M |
| Gross Margin | 28.5% | — |
| Operating Margin | 15.8% | 9.9% |
| Net Margin | 10.7% | 6.8% |
| Revenue YoY | 9.8% | -1.7% |
| Net Profit YoY | 19.7% | 10.5% |
| EPS (diluted) | $0.58 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $446.6M | $493.8M | ||
| Q3 25 | $447.7M | $492.9M | ||
| Q2 25 | $453.5M | $468.8M | ||
| Q1 25 | $416.5M | $458.4M | ||
| Q4 24 | $406.7M | $502.4M | ||
| Q3 24 | $403.7M | $511.2M | ||
| Q2 24 | $432.6M | $504.3M | ||
| Q1 24 | $426.6M | $495.1M |
| Q4 25 | $48.0M | $33.7M | ||
| Q3 25 | $54.8M | $71.7M | ||
| Q2 25 | $59.9M | $39.3M | ||
| Q1 25 | $44.7M | $20.7M | ||
| Q4 24 | $40.1M | $30.5M | ||
| Q3 24 | $43.8M | $19.4M | ||
| Q2 24 | $56.2M | $-153.0M | ||
| Q1 24 | $45.5M | $4.0M |
| Q4 25 | 28.5% | — | ||
| Q3 25 | 28.9% | — | ||
| Q2 25 | 28.9% | — | ||
| Q1 25 | 26.5% | — | ||
| Q4 24 | 26.3% | — | ||
| Q3 24 | 27.6% | — | ||
| Q2 24 | 30.5% | — | ||
| Q1 24 | 26.2% | — |
| Q4 25 | 15.8% | 9.9% | ||
| Q3 25 | 18.3% | 13.8% | ||
| Q2 25 | 18.0% | 12.8% | ||
| Q1 25 | 15.6% | 7.0% | ||
| Q4 24 | 13.4% | 7.8% | ||
| Q3 24 | 15.7% | 6.6% | ||
| Q2 24 | 18.4% | -31.3% | ||
| Q1 24 | 16.1% | 3.2% |
| Q4 25 | 10.7% | 6.8% | ||
| Q3 25 | 12.2% | 14.5% | ||
| Q2 25 | 13.2% | 8.4% | ||
| Q1 25 | 10.7% | 4.5% | ||
| Q4 24 | 9.9% | 6.1% | ||
| Q3 24 | 10.8% | 3.8% | ||
| Q2 24 | 13.0% | -30.3% | ||
| Q1 24 | 10.7% | 0.8% |
| Q4 25 | $0.58 | $0.40 | ||
| Q3 25 | $0.66 | $0.84 | ||
| Q2 25 | $0.72 | $0.46 | ||
| Q1 25 | $0.54 | $0.24 | ||
| Q4 24 | $0.49 | $0.37 | ||
| Q3 24 | $0.52 | $0.23 | ||
| Q2 24 | $0.67 | $-1.84 | ||
| Q1 24 | $0.54 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $236.4M | $375.2M |
| Total DebtLower is stronger | $570.0M | $570.5M |
| Stockholders' EquityBook value | $378.5M | $865.9M |
| Total Assets | $1.4B | $2.2B |
| Debt / EquityLower = less leverage | 1.51× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $236.4M | $375.2M | ||
| Q3 25 | $218.3M | $340.1M | ||
| Q2 25 | $190.8M | $224.7M | ||
| Q1 25 | $183.3M | $99.0M | ||
| Q4 24 | $184.3M | $229.9M | ||
| Q3 24 | $196.8M | $103.8M | ||
| Q2 24 | $160.5M | $19.4M | ||
| Q1 24 | $149.2M | $8.0M |
| Q4 25 | $570.0M | $570.5M | ||
| Q3 25 | $577.5M | $577.2M | ||
| Q2 25 | $585.0M | $583.9M | ||
| Q1 25 | $588.8M | $590.5M | ||
| Q4 24 | $592.5M | $597.1M | ||
| Q3 24 | $596.2M | — | ||
| Q2 24 | $600.0M | — | ||
| Q1 24 | $600.0M | — |
| Q4 25 | $378.5M | $865.9M | ||
| Q3 25 | $336.7M | $890.7M | ||
| Q2 25 | $316.3M | $833.8M | ||
| Q1 25 | $265.3M | $789.2M | ||
| Q4 24 | $227.4M | $764.9M | ||
| Q3 24 | $221.2M | $732.5M | ||
| Q2 24 | $178.1M | $706.5M | ||
| Q1 24 | $121.8M | $856.2M |
| Q4 25 | $1.4B | $2.2B | ||
| Q3 25 | $1.3B | $2.2B | ||
| Q2 25 | $1.3B | $2.1B | ||
| Q1 25 | $1.2B | $2.0B | ||
| Q4 24 | $1.2B | $2.2B | ||
| Q3 24 | $1.2B | $2.1B | ||
| Q2 24 | $1.2B | $2.0B | ||
| Q1 24 | $1.1B | $2.2B |
| Q4 25 | 1.51× | 0.66× | ||
| Q3 25 | 1.72× | 0.65× | ||
| Q2 25 | 1.85× | 0.70× | ||
| Q1 25 | 2.22× | 0.75× | ||
| Q4 24 | 2.61× | 0.78× | ||
| Q3 24 | 2.70× | — | ||
| Q2 24 | 3.37× | — | ||
| Q1 24 | 4.93× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $47.5M | $114.1M |
| Free Cash FlowOCF − Capex | $31.2M | — |
| FCF MarginFCF / Revenue | 7.0% | — |
| Capex IntensityCapex / Revenue | 3.6% | — |
| Cash ConversionOCF / Net Profit | 0.99× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $148.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $47.5M | $114.1M | ||
| Q3 25 | $82.1M | $137.3M | ||
| Q2 25 | $44.4M | $137.2M | ||
| Q1 25 | $28.7M | $-117.5M | ||
| Q4 24 | $20.0M | $133.0M | ||
| Q3 24 | $70.7M | $91.8M | ||
| Q2 24 | $22.9M | $107.0M | ||
| Q1 24 | $-8.2M | $-125.2M |
| Q4 25 | $31.2M | — | ||
| Q3 25 | $68.9M | — | ||
| Q2 25 | $32.4M | — | ||
| Q1 25 | $16.3M | — | ||
| Q4 24 | $10.0M | — | ||
| Q3 24 | $54.3M | — | ||
| Q2 24 | $11.3M | — | ||
| Q1 24 | $-18.8M | — |
| Q4 25 | 7.0% | — | ||
| Q3 25 | 15.4% | — | ||
| Q2 25 | 7.1% | — | ||
| Q1 25 | 3.9% | — | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 13.5% | — | ||
| Q2 24 | 2.6% | — | ||
| Q1 24 | -4.4% | — |
| Q4 25 | 3.6% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 2.6% | — | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 4.1% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 2.5% | — |
| Q4 25 | 0.99× | 3.39× | ||
| Q3 25 | 1.50× | 1.91× | ||
| Q2 25 | 0.74× | 3.49× | ||
| Q1 25 | 0.64× | -5.66× | ||
| Q4 24 | 0.50× | 4.36× | ||
| Q3 24 | 1.61× | 4.72× | ||
| Q2 24 | 0.41× | — | ||
| Q1 24 | -0.18× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATMU
| Fuel Products | $219.1M | 49% |
| Lube | $84.8M | 19% |
| Air | $74.0M | 17% |
| Other | $68.7M | 15% |
| Related Party | $14.9M | 3% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
